Top 10 Pharmaceutical Companies 2018

The global pharmaceutical market was estimated at USD 1.11 trillion in 2017 and projected to reach USD 1.43 trillion by 2020. In 2017, North America, Asia Pacific and Western Europe pharmaceutical market approximately accounted for 37%, 22% and 20% global market share respectively. 

In 2017, top-10 global pharmaceutical companies generated sales of USD 437.257 billion accounting for roughly 40% global market share and top-15 global pharmaceutical companies generated sales of USD 568.617 billion accounting for 51% global market share. A comparative analysis of the top-15 organizations was used to develop a ranking for these companies.

The ranking model incorporated seven criteria for each organization with focus on revenues generated by pharmaceutical products and growth in pharmaceutical revenues (2016 – 2017). The criteria includes pharmaceutical revenues, annual pharmaceutical revenue growth, total R&D expense, total expense, total income, proportion of revenue from top three pharmaceutical products and revenue per employee. A score statistic was developed based on these selected criteria. Each company was assigned a score for each criteria and a weighted sum was used to arrive at the final score statistic. Pharmaceutical revenue received the highest weight (45%) while revenue from top 3 products (5%) receives the lowest. The score statistic represented the pharmaceutical financial health and diversity of product portfolio of each company.

Αυτή είναι η πραγματικότητα στο χώρο του φαρμάκου

Με αφορμή την υπόθεση Novartis ο ΣΦΕΕ και το PhRMA Innovation Forum με μια μακροσκελή κοινή ανακοίνωσή τους δηλώνουν ότι καταδικάζουν οποιαδήποτε παράνομη πράξη, επισημαίνουν, ωστόσο, ότι ο δημόσιος διάλογος περιλαμβάνει ανακρίβειες, υπερβολές και φήμες, οι οποίες δημιουργούν -εσκεμμένα ή μη- λανθασμένες εντυπώσεις και επηρεάζουν αρνητικά τους ασθενείς και την κοινή γνώμη, δημιουργώντας έντονη ανασφάλεια και αμφισβήτηση, ενώ επιχειρούν να μηδενίσουν τη συνεισφορά ενός ολόκληρου κλάδου όχι μόνο στην υγεία των πολιτών αλλά και στην εθνική οικονομία.

Οι δύο φορείς, παραθέτουν ορισμένα βασικά δεδομένα που σχετίζονται με το χώρο του φαρμάκου, τονίζοντας ότι το πλαίσιο λειτουργίας του είναι υπερ-ρυθμισμένο από το Κράτος, και ίσως άγνωστο στο ευρύ κοινό:

Ασθενείς και Δημόσιο Σύστημα Υγείας

Η περίοδος 1995-2010 χαρακτηρίζεται κυρίως από την επανάσταση στην τεχνολογία και την ιατρική καινοτομία με την εισαγωγή πολλών νέων καινοτόμων φαρμάκων και σωτήριων θεραπειών – στον καρκίνο, τη Σκλήρυνση κατά Πλάκας, σημαντικό αριθμό Σπάνιων Παθήσεων κοκ – που οδήγησαν σε αύξηση του προσδόκιμου ζωής.

Top Women in Medical Sales: Smashing the Right Plates

Women are outnumbered in medical sales. In fact, in the 2017 Medical Sales Salary Report, 70 percent of the respondents were men. In addition, the report found that women earn just 83 percent of what men do and make up only 30 percent of the respondents.

While this picture seems bleak, if you look for them, you will find highly successful women in medical sales. We’re talking to these professionals to find out what it means to be a woman in the field and what it takes to be successful.

If you would have asked Emma Tod two years ago which direction her career was going, she never would’ve uttered a title involving ‘manager.’ Now, as the manager of the national strategic accounts team at Allergan, Tod still isn’t a fan of that specific title. Instead, she prefers to fall under the category of ‘leader.’

As a leader, Tod’s passions are deeply rooted in growing large, corporate accounts alongside her team. But work isn’t the only place you’ll find her enjoying her time. Tod spends much of her time on her two greater passions: her children and rowing.